Certara Products - Phoenix Archives

On-Demand Webinar

Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace

See how Phoenix NLME and RsNLME support scalable and manageable workflows as project demands evolve.

Danielle Pillsbury2026年5月8日

Blog

What We Learned at Phoenix UGM at Certainty 2026 About the Future of PK/PD

JTVCdGVhbV9qdW1wX2xpc3QlNUQ= 2026年5月8日 At Certainty 2026, the Phoenix User Group Meeting brought together scientists,…

Certara2026年5月8日

On-Demand Webinar

Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint

Explore how Phoenix NLME and RsNLME support early phase clinical pharmacology workflows where speed, clarity,…

Certara2026年5月6日

Blog

GxP Compliance in the Cloud: What IT Teams Need to Rethink

Learn how GxP validation works in modern SaaS and cloud environments, with best practices for…

Certara2026年5月4日

Webinar

Allometric Approach in pharmacokinetics when and how to use it

Danielle Pillsbury2026年4月28日

Webinar

When pharmacokinetics meets pharmacogenomics: Genetic Insights into Fluoxetine PK for Personalized Antidepressant Therapy

Certara2026年4月10日

Blog

PK Parameters Explained: From Cmax to Clearance (and Why It Matters for Development Decisions)

Learn how key PK parameters such as Cmax, AUC, clearance, half life, and volume of…

Certara2026年4月9日

Webinar

Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations

Danielle Pillsbury2026年4月2日

Case Study

Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection

PK/PD Modeling for CNS drug development using Phoenix NLME and machine learning for better CNS…

Certara2026年3月26日

Publication

Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis

This study evaluated the pharmacokinetics (PK) and pharmacokinetic–pharmacodynamic (PK–PD) relationship of clazakizumab, an anti–interleukin-6 (IL-6)…

Danielle Pillsbury2026年3月24日

Powered by Translations.com GlobalLink Web Software

Certara Products – Phoenix

Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace

What We Learned at Phoenix UGM at Certainty 2026 About the Future of PK/PD

Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint

GxP Compliance in the Cloud: What IT Teams Need to Rethink

Allometric Approach in pharmacokinetics when and how to use it

When pharmacokinetics meets pharmacogenomics: Genetic Insights into Fluoxetine PK for Personalized Antidepressant Therapy

PK Parameters Explained: From Cmax to Clearance (and Why It Matters for Development Decisions)

Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations

Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection

Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis

メルマガ登録

クイックアクセス

ソリューション

お問合せ